Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate (ASP); aroma ingredients, including vanillin and ethyl vanillin, natural vanillin, and some of its combinations; performance chemicals that include Hydroquinone (HQ), Catechol (CAT), Monomethyl Ether of HQ (MEHQ), tert butylcatechol (TBC), Guaiacol, and Veratrole; and health and wellness products comprising algae based products, such as Omega 3 fatty acids. It sells its prodycrts under the Xtendra, Nasure, Ezential, adorr, Dinamic, and Biosus brands. The company’s products are used in food and beverage, pet food and rendering, animal nutrition, petrochemical, nutrition and health, biofuel, agr
| Current Price | ₹118.10 |
|---|---|
| Market Cap | ₹2,269 Cr |
| Sector | Materials > Materials > Chemicals |
| Sub-Industry | Specialty Chemicals > Aromatics |
| P/E Ratio | -81.4 |
| Return on Equity | -3.36% |
| 52-Week Range | ₹96.21 – ₹327.53 |
| Beta (1Y) | 0.81 |
| Dividend Yield | 0.00% |
1. Speciality Chemicals-100%
Camlin Fine Sciences Ltd. is trading at ₹118.10, with a market capitalisation of ₹2,269 Cr.
Camlin Fine Sciences Ltd. operates in the Materials > Materials > Chemicals space (Specialty Chemicals > Aromatics).
Camlin Fine Sciences Ltd. has a P/E of -81.4 and a return on equity of -3.36%.